Russell Investments Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-20,964
Closed -$24.3K 3562
2023
Q1
$24.3K Sell
20,964
-63,415
-75% -$116K ﹤0.01% 2792
2022
Q4
$226K Buy
84,379
+12,305
+17% +$32.4K ﹤0.01% 2543
2022
Q3
$205K Buy
72,074
+11,762
+20% +$50K ﹤0.01% 2541
2022
Q2
$298K Buy
+60,312
New +$316K ﹤0.01% 2435
2021
Q1
Sell
-835
Closed -$74K 3216
2020
Q4
$74K Buy
+835
New +$70.2K ﹤0.01% 2891

Other funds holding CELL

Russell Investments Group's CELL Position: Q2 2023 in Review

Russell Investments Group sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 20,964 shares — an estimated $24.3K sold.

Russell Investments Group first reported a position in CELL in Q4 2020 and held it in 5 quarters. The position peaked at $298K in Q2 2022. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Russell Investments Group reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Russell Investments Group sold 20,964 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $24.3K.
  • Russell Investments Group first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Russell Investments Group's PhenomeX Inc. Common Stock position peaked at $298K in Q2 2022.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Russell Investments Group's 13F filing for Q2 2023, filed 10 Aug 2023.